Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation

Ravi S. Chari, Bradley H. Collins, John C. Magee, J. Michael Dimaio, Allan D. Kirk, Robert C. Harland, Richard L. Mccann, Jeffrey L. Platt, William C. Meyers

Research output: Contribution to journalArticle

237 Scopus citations

Abstract

In 1990, more than 27,000 patients died of liver failure in the United States1. Perfusion through a liver from another person or a member of another species, such as a monkey, outside the body was used in the past to stabilize the condition of some patients with acute or subacute liver failure25. Few patients survived, however, and this approach was superseded by orthotopic liver transplantation6. Liver transplantation is associated with higher mortality for patients with fulminant hepatic failure than for patients with chronic liver disease, however. Patients with fulminant hepatic failure often have multiorgan failure and.

Original languageEnglish (US)
Pages (from-to)234-237
Number of pages4
JournalNew England Journal of Medicine
Volume331
Issue number4
DOIs
StatePublished - Jul 28 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation'. Together they form a unique fingerprint.

  • Cite this

    Chari, R. S., Collins, B. H., Magee, J. C., Dimaio, J. M., Kirk, A. D., Harland, R. C., Mccann, R. L., Platt, J. L., & Meyers, W. C. (1994). Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. New England Journal of Medicine, 331(4), 234-237. https://doi.org/10.1056/NEJM199407283310404